Status:

UNKNOWN

The Efficacy of Intermittent Versus Daily Oral Iron Supplementation in Anaemic Pregnant Women.

Lead Sponsor:

Martini Hospital Groningen

Collaborating Sponsors:

dr. J.M. Munster, gynaecologist, principal investigator

Conditions:

Iron Deficiency Anemia

Pregnancy Related

Eligibility:

FEMALE

18+ years

Phase:

PHASE4

Brief Summary

In this study intermittent dosage of iron supplementation three times a week will be compared to daily dosage in anaemic pregnant women due to iron deficiency.

Detailed Description

Background of the study: Iron deficiency anaemia in pregnancy is common and the standard treatment is iron supplementation once or twice daily. But there is no evidence for the optimal dose of iron s...

Eligibility Criteria

Inclusion

  • Pregnant women of 18 years and older
  • Iron deficiency anaemia (defined as: Anaemia (haemoglobin lower than cut-off value) AND mean corpuscular volume (MCV) 70-85 fl OR ferritin \<30ug/L) OR mean corpuscular volume (MCV) \< 70fl / hemoglobinopathy is ruled out.
  • Adequate mental health
  • Good command of the Dutch language
  • No participation in other research with medication
  • Informed consent

Exclusion

  • Start of iron supplementation at pregnancy duration \> 37 weeks (because of the limited time to achieve an increase in haemoglobin).
  • History of bariatric surgery, inflammatory bowel disease, coeliac disease or Helicobacter pylori infection (because of malabsorption of iron).
  • Patients who received blood transfusion or parental iron supplementation during the 3 months prior to screening (because of the effect on the haemoglobin level).
  • Patients with significant bleeding, blood donation or surgery during pregnancy (because of the effect on the haemoglobin level).
  • Allergy for iron.
  • Anaemia of other cause, such as a hemoglobinopathy.

Key Trial Info

Start Date :

January 7 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2022

Estimated Enrollment :

58 Patients enrolled

Trial Details

Trial ID

NCT05278793

Start Date

January 7 2022

End Date

December 1 2022

Last Update

March 14 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Martini Hospital Groningen

Groningen, Netherlands, 9728 NT